Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mandler, R.
Right arrow Articles by Valenzuela, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandler, R.
Right arrow Articles by Valenzuela, R.
NEUROLOGY 1982;32:296
© 1982 American Academy of Neurology

Value of central nervous system IgG daily synthesis determination in the diagnosis of multiple sclerosis

Raul Mandler, M.D., Hershel Goren, M.D. and Rafael Valenzuela, M.D.

Departments of Neurology (Drs. Mandler and Goren) and Immunopathology (Dr Valenzuela), The Cleveland Clinic Foundation, Cleveland, OH.

Using laser beam immunonephelometry, we confirmed the value of Tourtellotte's formula in the diagnosis of MS. Moreover, since immunonephelometry presents several advantages, including simplicity, rapidity, and precision, it is a promising technique for the diagnosis of MS. Complicated measurements are not necessary. Determinations take only minutes. The results are reproducible. Mathematical manipulations are simple with readily available computers.

Address correspondence and reprint requests to Dr. Goren, Department of Neurology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44106.

Accepted for publication August 13, 1981.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by AAN Enterprises, Inc.